Clinical Trials
3 trialsNCT06790420 2026-05-15
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Completed
NCT07200583 2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
NCT07233720 2025-11-18
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Recruiting